MissionIR Articles

VistaGen Therapeutics, the ingenious biotech firm advancing potentially game-changing technology via a spectrum approach that combines the company’s Human Clinical Trials in a Test Tube™ platform with aggressive, novel chemical variation drug rescue of once-promising…

VistaGen, a California-based developer of advanced stem cell technologies to create superior drug testing options for pharmaceutical companies, considers strategic collaborators as a cornerstone of its corporate development strategy. To this end, VistaGen has selected…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, today issued the following letter to its stockholders and the investment community from its CEO, Shawn Singh. To our valued Stockholders: Since becoming…

The business model used by VistaGen Therapeutics targets the billions of dollars spent by the pharmaceutical industry to discover, optimize, and validate the potential efficacy of new drug candidates, taking a drug candidate all the…

Human pluripotent stem cells are the foundation for VistaGen’s development of advanced stem cell technologies to create superior drug testing opportunities for pharmaceutical companies. Pluripotent stem cells are able to self-renew as well as differentiate…

VistaGen Therapeutics, Inc., a biotechnology company applying stem cell technology for drug rescue, just announced it has secured a new United States patent covering the company’s proprietary methods used to measure and type the toxic…

Traditionally, the fundamental value of a company was based upon the potential of its products in the marketplace and the future earnings those products could support. In short, the value of a company centered around…

Today before the opening bell, VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, announced it has licensed breakthrough stem cell culture technology from the McEwen Centre for Regenerative Medicine located at…

VistaGen Therapeutics is, in a sense, turning the world of drug development and testing upside down with its proprietary pluripotent stem cell technology platform called Human Clinical Trials in a Test Tube. VistaGen’s stem cell…

Regenerative Medicine (RM), the use of advanced technologies to regenerate or replace human cells, tissues, or organs, has become such an important field, holding such recognized potential that there is a major effort to help…

VistaGen Therapeutics, Inc., a biotechnology company applying stem cell technology for drug rescue and cell therapy, just announced that it has entered into a strategic collaboration with Vala Sciences, Inc., a biotechnology company developing and…

Currently in Phase 1b clinical development, VistaGen Therapeutics’ lead drug candidate, AV-101, is showing promising potential for the treatment of neuropathic pain and depression. These are huge markets with notable growth prospects, and the unique…

One of the clear contributors to the exploding price of healthcare is the cost of researching a new drug and bringing it successfully to market. The cost of drug development has grown enormously over the…

VistaGen Therapeutics just announced that it has entered into a strategic research collaboration with Duke University, one of the country’s premier academic research institutions, to combine their complementary expertise at the forefront of cardiac stem…

One of the fastest growing markets in healthcare is the field of neuropathic pain therapeutics. Neuropathic pain is the sensation of pain caused by damaged or dysfunctional nerves sending incorrect signals to the brain’s pain…

When it comes to modern medicine, stem cells are seen as playing a role unmatched by anything else. Used in a growing number of cell therapies for certain cancers, various diseases related to the immune…

VistaGen Therapeutics, Inc., a biotechnology company applying stem cell technology for drug rescue and cell therapy, has engaged MissionIR, a national investor relations consulting firm, to develop and implement a strategic investor relations campaign. Through…

VistaGen Therapeutics, Inc., a biotechnology company applying stem cell technology for drug rescue and cell therapy, today announced the identification of its initial Top 10 drug rescue candidates. The company plans to launch two formal…

An increasingly important word in drug development today is focus, the ability to understand the genetic makeup of a target patient population so that the hyper-expensive process of discovering and developing drugs will have an…

VistaGen Therapeutics, Inc., a biotechnology company applying stem cell technology for drug rescue and cell therapy, today announced it has expanded its long-term relationship with Cato BioVentures and Cato Research to include right-of-first-offer for potential…